Moderna, Japan partner recall 1.6 million doses of coronavirus vaccine
Team Udayavani, Sep 2, 2021, 1:12 PM IST
Image for representation
Tokyo: Moderna Inc. and its Japanese partner are recalling more than 1 million doses of the U.S. drug maker’s coronavirus vaccine after confirming that contamination reported last week was tiny particles of stainless steel.
Takeda Pharmaceutical Co. is in charge of sale and distribution in Japan of the Moderna vaccine. The two companies said an investigation at a Spanish factory that produced the vials in question concluded the contamination occurred in the process of putting stops on the vials.
The companies on Aug. 26 announced suspension of 1.63 million doses produced at the line after reports of contamination. Japanese officials said about a half million people had received shots from the Moderna vials before the problem surfaced.
The trouble comes at a time Japan is pushing to accelerate vaccinations amid rising infections that are straining the Japanese health care system.
Pharmaceutical and health ministry officials say they do not believe the high-grade stainless steel poses health risks.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Trump says India charges lot of tariff, threatens to impose reciprocal tax
Cyclone Chido hits French territory of Mayotte; Death toll is ‘several hundred,’ top official says
Sheikh Hasina mounts fresh attacks on Muhammad Yunus; accuses him of leading an “undemocratic group”
Tabla maestro Zakir Hussain in San Francisco ICU with heart problems
Ousted PM Sheikh Hasina involved in enforced disappearance: Bangladesh commission
MUST WATCH
Latest Additions
Assembly clears Mysuru Development Authority Bill
Blocked 18 OTT platforms for publishing obscene, vulgar content: Govt
Boy critically injured after tree branch falls on him in Bengaluru
Congress claims party worker ‘died due to tear gas smoke’ during protest in Assam
Four dead in road accident in Kolar
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.